Apr 2024 $11 M No. 6 $10 to $50 million 6
Manus Bio Inc.: Raise no. 6, Apr 2024 × Investors in this round 6 investors had bought by the notice of May 14, 2024: 6 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 9 investors are named for Manus Bio Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $11 M of $11 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them, other: Common Stock to be acquired upon exercise of option. Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Ajikumar Parayil Kumaran · Director, Executive Officer · Dr. Parayil is the Founder, President, and Chief Executive Officer of the Issuer. Julio A. Ruiz Calderon · Executive Officer · Mr. Ruiz Calderon is the Interim Chief Financial Officer of the Issuer. Alena A. Ivashenka · Director Jean A. Nehme · Director Michael A. Carlos · Director Rick A. Gerson · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Ajikumar Parayil Kumaran, President of the Issuer. Source: SEC Form D, newest notice filed May 14, 2024. Read the notice at the SEC .
equity, options SEC Aug 2021 $21 M No. 5 $10 to $50 million 14
Manus Bio Inc.: Raise no. 5, Aug 2021 × Investors in this round 14 investors had bought by the notice of May 31, 2023: 14 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 9 investors are named for Manus Bio Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $21 M of $22 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold equity, debt, options or other rights to buy securities, securities to be acquired by exercising them, other: Convertible promissory notes; Equity securities underlying convertible promissory notes. Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Ajikumar Parayil · Executive Officer, Director · Dr. Parayil is the Founder, President and Chief Executive Officer of the Issuer. Jeremiah Hux · Executive Officer · Mr. Hux is the Chief Financial Officer of the Issuer. Alena Ivashenka · Director John Nehme · Director Michael Carlos · Director Rick Gerson · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “The total offering amount includes the interest of 5% on the convertible promissory notes.”Signed by Ajikumar Parayil, President & CEO of the Issuer. Source: SEC Form D, newest notice filed May 31, 2023. Read the notice at the SEC .
equity, debt, options SEC Aug 2020 $66 M No. 4 $50 to $250 million 27
Manus Bio Inc.: Raise no. 4, Aug 2020 × Investors in this round 27 investors had bought by the notice of Nov 6, 2020: 27 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 9 investors are named for Manus Bio Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $66 M of $80 M offered; $14 M still to sell
Smallest investment taken no minimum stated
What was sold equity, other: Series B-1 Preferred Stock, Series B-2 Preferred Stock and Series B-3 Preferred Stock Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Ajikumar Parayil · Executive Officer, Director · Dr. Parayil is the Founder, President and Chief Executive Officer of the Issuer. Christine Santos · Executive Officer · Dr. Santos is the Secretary and Chief Technology Officer of the Issuer. Jeff Anderson · Executive Officer · Mr. Anderson is the Chief Operations Officer of the Issuer. Paul Boni · Executive Officer · Mr. Boni is the Chief Financial Officer of the Issuer. Bryon Alsberg · Director Colin Gounden · Director Gregory Stephanopoulos · Director Michael Carlos · Director Raymond Chang · Director Zanna McFerson · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Ajikumar Parayil, President and CEO of the Issuer. Source: SEC Form D, newest notice filed Nov 6, 2020. Read the notice at the SEC .
equity SEC Apr 2020 $66 M No. 3 $50 to $250 million 27
Manus Bio Inc.: Raise no. 3, Apr 2020 × Investors in this round 27 investors had bought by the notice of Nov 9, 2020: 27 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 9 investors are named for Manus Bio Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $66 M of $80 M offered; $14 M still to sell
Smallest investment taken no minimum stated
What was sold equity, other: Series B-1 Preferred Stock, Series B-2 Preferred Stock and Series B-3 Preferred Stock Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Ajikumar Parayil · Executive Officer, Director · Dr. Parayil is the Founder, President and Chief Executive Officer of the Issuer. Christine Santos · Executive Officer · Dr. Santos is the Secretary and Chief Technology Officer of the Issuer. Jeff Anderson · Executive Officer · Mr. Anderson is the Chief Operations Officer of the Issuer. Paul Boni · Executive Officer · Mr. Boni is the Chief Financial Officer of the Issuer. Bryon Alsberg · Director Colin Gounden · Director Gregory Stephanopoulos · Director Michael Carlos · Director Raymond Chang · Director Zanna McFerson · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Ajikumar Parayil, President and CEO of the Issuer. Source: SEC Form D, newest notice filed Nov 9, 2020. Read the notice at the SEC .
equity SEC Jun 2018 $10 M No. 2 $10 to $50 million 15
Manus Bio Inc.: Raise no. 2, Jun 2018 × Investors in this round 15 investors had bought by the notice of Jul 16, 2018: 15 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 9 investors are named for Manus Bio Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $10 M of $12 M offered; $2 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, other: Series A-1 Preferred Stock and Warrants to purchase Series A-1 Preferred Stock Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Ajikumar Parayil · Executive Officer, Director · Dr. Parayil is the Founder, President and Chief Executive Officer of the Issuer. Christine Santos · Executive Officer · Dr. Santos is the Secretary and Chief Technology Officer of the Issuer. Jeff Anderson · Executive Officer · Mr. Anderson is the Chief Operations Officer of the Issuer. Paul Boni · Executive Officer · Mr. Boni is the Chief Financial Officer of the Issuer. Bryon Alsberg · Director Colin Gounden · Director Gregory Stephanopoulos · Director Michael Carlos · Director Raymond Chang · Director Zanna McFerson · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Ajikumar Parayil, President and Chief Executive Officer of the Issuer. Source: SEC Form D, newest notice filed Jul 16, 2018. Read the notice at the SEC .
equity, options SEC Aug 2017 $9 M No. 1 $2 to $10 million 24
Manus Bio Inc.: Raise no. 1, Aug 2017 × Investors in this round 24 investors had bought by the notice of Dec 29, 2017: 24 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 9 investors are named for Manus Bio Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $9 M of $10 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Ajikumar Parayil · Executive Officer, Director Byron Alsberg · Director Carsten Boers · Director Colin Gounden · Director Gregory Stephanopoulos · Director Michael Carlos · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Ajikumar Parayil, President. Source: SEC Form D, newest notice filed Dec 29, 2017. Read the notice at the SEC .
equity SEC